Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
LJ International Inc.
Dutton Associates Announces Investment Opinion: LJ International Rating Maintained At Neutral By Dutton Associates
September 28th, 2008
Dutton Associates continues its coverage of LJ International Inc. (Nasdaq: JADE) with an update report maintaining its Neutral rating. The 13-page updated report by Dutton senior analyst Sally L. Wallick, CFA is available at www.jmdutton.com as well as from First Call, Bloomberg Professional, Capital IQ, FactSet, and other leading financial portals. LJI's 2Q 2008 revenue fell 6% year over year to $31.1 million. Retail revenue totaled approximately $7.9 million, down 24% as a result of a decline in sales of high-end jewelry, and wholesale revenue increased 2% to $23.2 million. LJI reported a 2Q net loss of $263,000 or $0.01 per share, versus a net profit of $1.2 million...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-28)
|
